Rolf Skotheim (photo) is the site responsible in Oslo, and says that across all types of cancer, testicular cancer is now the type for which known susceptibility genes explain the largest fraction the genetic risk.
Research by PhD student Deeqa Ahmed and colleagues at the Department of Cancer Prevention may provide improved colorectal cancer diagnostics. Identification of a set of biomarkers that has been licensed by Oxford Gene Technology may lead to new tests for early cancer detection.
Full story in Norwegian.
New group leader Guro E Lind received "Early Career award" from Oslo University hospital. Post doc Anita Sveen and colleagues were honored for "Excellent original article".
Department of Cancer Prevention receives funding from the Norwegian Research Council from the FORNY2020 and BIOTEK2021 programmes for innovation projects on colorectal cancer. Development of prognostic and predictive markers for CRC is led by professor Ragnhild A. Lothe with Dr.s Rolf I. Skotheim, Guro E. Lind and professor Arild Nesbakken as active partners.
Project presentation in Norwegian
Link til Dept Cancer prevention
Link til CCB
Drs Sigrid Marie Kraggerud, Christina Høi-Hansen and Sharmini Alagaratnam publish in Endrocrine Reviews, the highest ranked journal in the category of Endocrinology and metabolism with IF of 19.9.
Monday the 9th of April, Lind was invited to the radio program “Ekko” to talk about blood based testing for early detection of colorectal cancer.
The program (in Norwegian) can be heard here: nrk_ekko_-_et_aktuelt_samfunnsprogram_2013-0408-1238_6350102183.mp3
For the month of March 2013, this honor goes to professor Ragnhild A.Lothe, Genetics group, Department of Cancer Prevention at the Institute for Cancer Research.
From the web pages of South-Eastern Norway Regional Health Authority (in Norwegian):
Innovator of the month
A gene signature distinguishing the two cell types was identified, which included a number of cancer relevant and pluripotency genes. NR5A2 is an especially intriguing candidate given its role in the WNT-signalling pathway, which is often disrupted in cancer, and particularly so in colorectal cancer.
Link to article
A study carried out at Edward Leithe’s project group at Department of Cancer Prevention has been awarded a prize for Excellent Research Article by the Oslo University Hospital. The prize was presented on Friday 26th October and carries an award of 50,000 kr.